H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 114 Citations 48,808 445 World Ranking 2042 National Ranking 23

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Asthma

Josep M. Antó mostly deals with Asthma, Physical therapy, COPD, Internal medicine and Risk factor. Josep M. Antó combines subjects such as Odds ratio, Epidemiology, Pediatrics and Environmental health with his study of Asthma. His Physical therapy research incorporates themes from Cross-sectional study, Quality of life, Chronic bronchitis, Obstructive lung disease and Cohort.

He has included themes like Respiratory disease, FEV1/FVC ratio, Rate ratio, Chronic cough and Spirometry in his COPD study. As a part of the same scientific study, Josep M. Antó usually deals with the Risk factor, concentrating on Exacerbation and frequently concerns with Case-control study. His Allergy study, which is part of a larger body of work in Immunology, is frequently linked to Sputum, bridging the gap between disciplines.

His most cited work include:

  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017 : a systematic analysis for the Global Burden of Disease Study 2017 (1257 citations)
  • Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (849 citations)
  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016 (788 citations)

What are the main themes of his work throughout his whole career to date?

Josep M. Antó mainly focuses on Asthma, Internal medicine, Immunology, COPD and Allergy. The study incorporates disciplines such as Odds ratio, Epidemiology, Pediatrics and Environmental health in addition to Asthma. His Epidemiology study combines topics in areas such as Surgery, Incidence and Public health.

His Environmental health study which covers Risk factor that intersects with Relative risk. Josep M. Antó interconnects Respiratory disease, Pulmonary disease, Exacerbation, Physical therapy and Cohort in the investigation of issues within COPD. His work deals with themes such as Prospective cohort study and Quality of life, which intersect with Physical therapy.

He most often published in these fields:

  • Asthma (44.70%)
  • Internal medicine (21.40%)
  • Immunology (20.27%)

What were the highlights of his more recent work (between 2017-2021)?

  • Asthma (44.70%)
  • Allergy (17.23%)
  • Environmental health (14.02%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Asthma, Allergy, Environmental health, Internal medicine and COPD. His Asthma study results in a more complete grasp of Immunology. As a part of the same scientific family, he mostly works in the field of Immunology, focusing on Methylation and, on occasion, CpG site.

Josep M. Antó focuses mostly in the field of Environmental health, narrowing it down to matters related to Risk factor and, in some cases, Disease burden. His studies examine the connections between COPD and genetics, as well as such issues in Disease, with regards to Epidemiology. His Visual analogue scale research is multidisciplinary, relying on both Quality of life and Nose.

Between 2017 and 2021, his most popular works were:

  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017 : a systematic analysis for the Global Burden of Disease Study 2017 (1257 citations)
  • DNA methylation in childhood asthma: an epigenome-wide meta-analysis (93 citations)
  • Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (78 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Cancer

His scientific interests lie mostly in Asthma, Environmental health, Allergy, mHealth and Disease. His Asthma study improves the overall literature in Internal medicine. His study in the field of Quality of life is also linked to topics like Mobile technology.

His Environmental health study integrates concerns from other disciplines, such as Mortality rate, Pregnancy and Risk factor. His work carried out in the field of Allergy brings together such families of science as Visual analogue scale, Human leukocyte antigen and Genome-wide association study. The Disease study combines topics in areas such as Differentially methylated regions, DNA methylation, COPD and Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017 : a systematic analysis for the Global Burden of Disease Study 2017

Jeffrey D. Stanaway;Ashkan Afshin;Emmanuela Gakidou;Stephen S. Lim.
The Lancet (2018)

1981 Citations

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016

Amanuel Alemu Abajobir;Kalkidan Hassen Abate;Cristiana Abbafati;Kaja M. Abbas.
(2017)

1505 Citations

Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study

Judith Garcia-Aymerich;Peter Lange;Marta Benet;Peter Schnohr.
Thorax (2006)

1157 Citations

The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma

B Abraham;JM Anto;E Barreiro;Ehd Bel.
European Respiratory Journal (2003)

977 Citations

Risk factors of readmission to hospital for a COPD exacerbation: a prospective study

J Garcia-Aymerich;E Farrero;M A Félez;J Izquierdo.
Thorax (2003)

918 Citations

Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

Joan B Soriano;Joan B Soriano;Amanuel Alemu Abajobir;Kalkidan Hassen Abate;Semaw Ferede Abera.
The Lancet Respiratory Medicine (2017)

849 Citations

[The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results].

J Alonso;L Prieto;J M Antó.
Medicina Clinica (1995)

680 Citations

Epidemiology of chronic obstructive pulmonary disease

J M Anto;P Vermeire;J Vestbo;J Sunyer.
European Respiratory Journal (2001)

625 Citations

Chronic Obstructive Pulmonary Disease Stage and Health-Related Quality of Life

M Ferrer;J Alonso;J Morera;R M Marrades.
Annals of Internal Medicine (1997)

597 Citations

COPD in never smokers: results from the population-based burden of obstructive lung disease study.

Bernd Lamprecht;Mary Ann McBurnie;William M. Vollmer;Gunnar Gudmundsson.
Chest (2011)

586 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Josep M. Antó

Jean Bousquet

Jean Bousquet

Inserm : Institut national de la santé et de la recherche médicale

Publications: 232

Christer Janson

Christer Janson

Uppsala University

Publications: 164

Marc Miravitlles

Marc Miravitlles

Instituto de Salud Carlos III

Publications: 152

Deborah Jarvis

Deborah Jarvis

Imperial College London

Publications: 151

Jordi Sunyer

Jordi Sunyer

Pompeu Fabra University

Publications: 141

Joachim Heinrich

Joachim Heinrich

Ludwig-Maximilians-Universität München

Publications: 129

Alvar Agusti

Alvar Agusti

University of Barcelona

Publications: 124

Erik Melén

Erik Melén

Karolinska Institute

Publications: 116

Jørgen Vestbo

Jørgen Vestbo

University of Manchester

Publications: 115

Rudolf Valenta

Rudolf Valenta

Medical University of Vienna

Publications: 113

Joan B. Soriano

Joan B. Soriano

Instituto de Salud Carlos III

Publications: 111

Pascal Demoly

Pascal Demoly

University of Montpellier

Publications: 110

Cecilie Svanes

Cecilie Svanes

University of Bergen

Publications: 108

Bartolome R. Celli

Bartolome R. Celli

Brigham and Women's Hospital

Publications: 107

Mark J. Nieuwenhuijsen

Mark J. Nieuwenhuijsen

Pompeu Fabra University

Publications: 107

Claus Bachert

Claus Bachert

Ghent University

Publications: 102

Something went wrong. Please try again later.